Newly detected atrial fibrillation and compliance with antithrombotic guidelines

Nicole L Glazer1, Sascha Dublin, Nicholas L Smith

  • 1Cardiovascular Health Research Unit and Department of Epidemiology, University of Washington, 1730 Minor Avenue, Seattle, WA 98101, USA. nlg@u.washington.edu

Insights

Most patients with newly detected atrial fibrillation (AF) received antithrombotic therapy. However, warfarin use in high-risk patients was influenced more by AF classification than stroke risk factors.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Guidelines recommend antithrombotic therapy for stroke prevention in atrial fibrillation (AF).
  • Compliance with these guidelines in newly detected AF is not well-studied.
  • Need to identify patient characteristics associated with warfarin use.

Purpose of the Study:

  • Assess compliance with antithrombotic guidelines in newly detected AF.
  • Identify patient characteristics associated with warfarin use.

Main Methods:

  • Population-based study of newly detected AF (ages 30-84) within a large health plan.
  • Abstracted cardiovascular risk factors, comorbidities, and medication use.
  • Stratified patients by embolic risk (ACCP criteria) and analyzed antithrombotic use (warfarin/aspirin) within 6 months post-AF onset.
  • Used relative risk regression to associate risk factors with warfarin use.

Main Results:

  • 73% of patients with newly detected AF received antithrombotic therapy.
  • Among high-risk patients (76%), 59% used warfarin, 28% used aspirin, and 24% used neither.
  • AF classification (intermittent/sustained) was a major predictor of warfarin use (RR 2.8-2.9) compared to transitory AF.

Conclusions:

  • Three-quarters of patients with newly detected AF received antithrombotic therapy.
  • Many high-risk patients did not receive warfarin.
  • AF classification, not stroke risk factors, strongly predicted warfarin use.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...